Comparison among ultra-thin coronary stents: a network meta-analysis
G Marengo, F Bruno, L Scudeler, F Savoca… - The American journal of …, 2024 - Elsevier
Ultrathin-strut drug-eluting stents (DES) have been related to potential improvement in stent-
related outcomes compared with thicker-struts DES. However, comparisons among different …
related outcomes compared with thicker-struts DES. However, comparisons among different …
[HTML][HTML] Twelve months clinical outcomes of ultrathin strut sirolimus-eluting stent in real-world Indian patients with coronary artery disease
P Ajmera, R Pothineni, KK Chawla… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Purpose: Although the field of interventional cardiology has witnessed extraordinary
progression, the search of an ideal coronary drug-eluting stent is still going on. Tetriflex …
progression, the search of an ideal coronary drug-eluting stent is still going on. Tetriflex …
Rationale and design of the TUXEDO-2 India study: ultra-thin strUt Supraflex Cruz versus XiencE in a Diabetic pOpulation with Multi-vessel Disease–2
U Kaul, P Arambam, SK Sinha, R Abhaichand… - American Heart …, 2023 - Elsevier
Background The role of percutaneous coronary interventions (PCI) in patients with diabetes
mellitus and multi-vessel disease has been questioned by the results of the FREEDOM trial …
mellitus and multi-vessel disease has been questioned by the results of the FREEDOM trial …
Comparative effectiveness of ultrathin vs. standard strut drug-eluting stents: insights from a large-scale meta-analysis with extended follow-up
A Hassan, AM Amin, AF Gadelmawla… - European Journal of …, 2024 - Springer
Background Newer generation ultrathin strut stents are associated with less incidence of
target lesion failure (TLF) in patients undergoing percutaneous coronary intervention (PCI) …
target lesion failure (TLF) in patients undergoing percutaneous coronary intervention (PCI) …
In‐Hospital and 1‐Year Clinical Results from the French Registry Using Polymer‐Free Sirolimus‐Eluting Stents in Acute Coronary Syndrome and Stable Coronary …
Q Landolff, M Quillot, F Picard, P Henry… - Journal of …, 2023 - Wiley Online Library
Objectives. The aim of this postmarket clinical study was to assess the safety and efficacy of
the latest generation polymer‐free sirolimus‐eluting stents (PF‐SES) in an all‐comers …
the latest generation polymer‐free sirolimus‐eluting stents (PF‐SES) in an all‐comers …
[HTML][HTML] Ultrathin, biodegradable polymer-coated everolimus-eluting stents for patients undergoing percutaneous coronary intervention: Final three-year results of the …
S Kasturi, S Polasa, MA Sowdagar, P Kumar… - Indian Heart …, 2023 - Elsevier
The registry reports 3-year safety and clinical performance of the ultrathin strut (60 μm)
biodegradable polymer-coated Tetrilimus, an everolimus-eluting stent (EES)(Sahajanand …
biodegradable polymer-coated Tetrilimus, an everolimus-eluting stent (EES)(Sahajanand …
DES strut thickness and clinical outcomes after CTO recanalization: Insights from LATAM CTO registry
SF Câmara, CM Campos, RD Machado… - Cardiovascular …, 2023 - Elsevier
Background Ultra-thin strut drug-eluting stent (UTS-DES) may improve outcomes after
percutaneous coronary intervention (PCI) but have received limited study in chronic total …
percutaneous coronary intervention (PCI) but have received limited study in chronic total …
[HTML][HTML] 3-Year clinical outcomes of ultrathin biodegradable polymer-coated sirolimus-eluting stents: T-flex registry with high-risk subgroups
RB Pothineni, V Vijan, A Potdar, MK Inamdar, A Pathak… - JACC: Asia, 2022 - jacc.org
Second-generation drug-eluting stents (DES) displayed supreme advantages over bare-
metal stents and first-generation DES by subduing restenosis, instent restenosis, and stent …
metal stents and first-generation DES by subduing restenosis, instent restenosis, and stent …